Balchem Stock Today
| BCPC Stock | USD 179.69 2.63 1.44% |
Performance4 of 100
| Odds Of DistressLess than 3
|
Balchem is trading at 179.69 as of the 28th of November 2024, a 1.44% down since the beginning of the trading day. The stock's open price was 182.32. Balchem has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Balchem are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of September 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Materials | IPO Date 3rd of June 1986 | Category Basic Materials |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. The company has 32.51 M outstanding shares of which 442.21 K shares are currently shorted by private and institutional investors with about 3.55 trading days to cover. More on Balchem
Moving together with Balchem Stock
Moving against Balchem Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Balchem Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO and President and Director | Theodore Harris | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Chemicals Makers (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Specialty Chemicals, Basic Materials, NASDAQ Composite, SP Small-Cap 600, Chemicals Makers, Materials, Chemicals, Specialty Chemicals, Basic Materials (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBalchem can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Balchem's financial leverage. It provides some insight into what part of Balchem's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balchem (BCPC) is traded on NASDAQ Exchange in USA. It is located in 5 Paragon Drive, Montvale, NJ, United States, 07645 and employs 1,300 people. Balchem is listed under Specialty Chemicals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.93 B. Balchem conducts business under Chemicals sector and is part of Materials industry. The entity has 32.51 M outstanding shares of which 442.21 K shares are currently shorted by private and institutional investors with about 3.55 trading days to cover.
Balchem currently holds about 58.1 M in cash with 183.76 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81.
Check Balchem Probability Of Bankruptcy
Ownership AllocationBalchem holds a total of 32.51 Million outstanding shares. The majority of Balchem outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Balchem to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Balchem. Please pay attention to any change in the institutional holdings of Balchem as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Balchem Ownership Details
Balchem Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Jpmorgan Chase & Co | 2024-06-30 | 451.3 K | |
| Ameriprise Financial Inc | 2024-06-30 | 431 K | |
| Schroder Investment Management Group | 2024-06-30 | 418.3 K | |
| Clearbridge Advisors, Llc | 2024-09-30 | 405.9 K | |
| Norges Bank | 2024-06-30 | 387.5 K | |
| Northern Trust Corp | 2024-09-30 | 371.9 K | |
| Charles Schwab Investment Management Inc | 2024-09-30 | 362 K | |
| Congress Asset Management Company, Llp | 2024-09-30 | 301.4 K | |
| Stephens Inv Mgmt Group Llc | 2024-09-30 | 281.5 K | |
| Blackrock Inc | 2024-06-30 | 4.9 M | |
| Vanguard Group Inc | 2024-09-30 | 3.9 M |
Balchem Historical Income Statement
Balchem Stock Against Markets
Balchem Corporate Management
| Hatsuki Miyata | General VP | Profile | |
| William CPA | VP Officer | Profile | |
| Frederic Boned | Senior Health | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Brent Tignor | Senior Officer | Profile | |
| Carl Bengtsson | CFO Treasurer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Balchem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.144 | Dividend Share 0.79 | Earnings Share 3.74 | Revenue Per Share 29.208 | Quarterly Revenue Growth 0.043 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.